Study of Complications of Laparoscopic Cholecystectomy at Teaching Institute
European Journal of Clinical Pharmacy · 26.12.2025 · 7 (1) · 5687-5692
DOI: 10.61336/ejcp/25-01-643 ↗Kurz gefasst
Fachartikel in der Zeitschrift European Journal of Clinical Pharmacy, online erschienen am 26.12.2025.
Abstract (Originalsprache)
Background
Laparoscopic cholecystectomy is the standard surgical treatment for gallstone disease due to reduced pain, shorter hospitalization, and faster recovery compared to the open approach.
Objective
To determine the frequency and pattern of complications associated with laparoscopic cholecystectomy and identify factors associated with increased morbidity. Methodology: This was a descriptive, cross-sectional study conducted at Dara Welfare Hospital Kohat from May 2024 to May 2025 including 155 patients undergoing Laparoscopic cholecystectomy.
Results
Females constituted 65.2% of patients, and most were aged 31–45 years (43.2%). Overweight or obesity was observed in 60.6%, and comorbidities were present in 43.9%. Chronic cholecystitis (52.9%) was the most common indication. Laparoscopic completion was achieved in 91.6%, with conversion to open surgery in 8.4%. Intraoperative complications included gallbladder perforation (18.7%), bile spillage (15.5%), and bleeding (11.6%), while bile duct injury occurred in 1.3%. Postoperatively, fever (13.5%), surgical site infection (11.0%), and ileus (7.1%) were most frequent. Higher complication rates were significantly associated with diabetes (56.8%), obesity (61.3%), acute cholecystitis (59.1%), previous abdominal surgery (53.6%), and operative time >90 minutes (73.3%) (p < 0.05).
Conclusion
Laparoscopic cholecystectomy is a safe procedure with low major morbidity and mortality; however, complications are more frequent in patients with metabolic comorbidities, acute inflammation, and prolonged operative time. Careful risk assessment and surgical expertise are essential to optimize outcomes.
Zitieren
APA
(2025). Study of Complications of Laparoscopic Cholecystectomy at Teaching Institute. European Journal of Clinical Pharmacy, 7(1), 5687-5692. https://doi.org/10.61336/ejcp/25-01-643
Vancouver
Study of Complications of Laparoscopic Cholecystectomy at Teaching Institute. European Journal of Clinical Pharmacy. 2025;7(1):5687-5692. doi:10.61336/ejcp/25-01-643
BibTeX
@article{euvimed2025,
title = {Study of Complications of Laparoscopic Cholecystectomy at Teaching Institute},
journal = {European Journal of Clinical Pharmacy},
year = {2025},
volume = {7},
number = {1},
pages = {5687--5692},
doi = {10.61336/ejcp/25-01-643}
}
EUVIMED